A Double Blind, Placebo Controlled, Dose Escalation Trial of Glycerol Phenylbutyrate Corrector Therapy for Cystic Fibrosis
Not yet recruiting
Phase of Trial: Phase I/II
Latest Information Update: 03 Apr 2018
At a glance
- Drugs Glycerol phenylbutyrate (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- 27 Mar 2018 Planned initiation date changed from 1 Dec 2017 to 1 May 2018.
- 12 Sep 2017 Planned initiation date changed from 1 Aug 2017 to 1 Dec 2017.
- 10 Jun 2017 Biomarkers information updated